Recombinant Mycobacterium Tuberculosis Fusion Protein(EEC)

重组结核杆菌融合蛋白(EEC)

Report date: 2026/03/24 20:00:35

Base Information

Drug NameRecombinant Mycobacterium Tuberculosis Fusion Protein(EEC)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion proteinDiagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsDiagnostic agentsTuberculosis, PulmonaryTuberculosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesChengdu Keen Biological Technology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesChengdu Keen Biological Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsDiagnostic agentsTuberculosis, PulmonaryTuberculosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A